Charles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq

Stock Information for Arch Therapeutics Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Arch Therapeutics Inc

Charles & Colvard Partners with VideoShops to Bring Its Lab-Grown Jewelry and Customers to the Social Commerce Network with 50,000+ Influential Sellers
Charles & Colvard, Ltd. Announces Delisting from Nasdaq
Charles & Colvard, Ltd. Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
Charles & Colvard, Ltd. Receives Interim Award in Wolfspeed Arbitration
Charles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq
Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO
Charles & Colvard, Ltd. Comments on a Letter from Riverstyx Capital Management to Charles & Colvard Shareholders
CHARLES & COLVARD REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.